hepatitis b vaccination coverage among teaching hospitals workers in the urmia city ali gholami, tahereh alinia , leila moosavi jahromi * received: 25 april, 2010 accepted: 27 july, 2010 abstract introduction: hepatitis b virus infection is a well recognized risk for healthcare workers (hcws). for protect hcws of hepatitis b, vaccination has been recommended. the aim of this study is survey of...

BACKGROUND Hepatitis B is a serious global public health concern. Though a safe and efficacious recombinant vaccine is available, its use in several resource-poor countries is limited by cost. We have investigated the production of Hepatitis B virus surface antigen (HBsAg) using the yeast Pichia pastoris GS115 by inserting the HBsAg gene into the alcohol oxidase 1 locus. RESULTS Large-scale p...

Parenteral-transmitted viral hepatitis is a significant health problem in persons with hematological malignancies that is why prevention measures against them are needed. One of the most important interventions is the prophylactic vaccination against hepatitis B virus infection. The results of a clinical trial using the Cuban antihepatitis B recombinant DNA vaccine in a group of adult patients ...

Three cases of immune thrombocytopenic purpura after the first dose of recombinant hepatitis B vaccine occurred in infants under 6 months of age. Other possible causes of this condition were excluded. Antiplatelet antibodies were present. A defect in platelet production was excluded in two children. Corticosteroid treatment was effective. Subsequent administration of other vaccines (against pol...

results the results of this study indicated that the overall hepatitis b vaccine acceptance rate was acceptably high. among all, 53.5% correctly identified that a vaccine to prevent hepatitis b virus infection had been available, 15% had a negative opinion, and 31.5% were neutral. the rations of all three doses of vaccination were 69.3%. conclusions among the respondents, 87% were currently mar...

normal 0 false false false en-us x-none ar-sa microsoftinternetexplorer4 normal 0 false false false en-us x-none ar-sa microsoftinternetexplorer4 aim : in this study we co-administered melittin along with hbsag/alum vaccine to investigate if it helps elicitation of th1/th2 response. background : hepatitis b virus (hbv) infection is a life-threatening liver infection, which can lead to chronic l...

Hepatitis C virus (HCV) is the major etiologic agent of blood transfusion–associated and sporadic nonA non-B hepatitis affecting more than 180 million worldwide. Vaccine development for HCV has been difficult and there is no vaccine or effective therapy against this virus. In this paper, we describe the development of an experimental plant-derived subunit vaccine against HCV. Our subunit vaccin...

BACKGROUND AND AIM: Hepatitis B Virus (HBV), a DNA virus with a human-only reservoir, is a worldwide public health problem. Approximately 45.0% of the world’s population is considered to live in areas of high endemicity with a lifetime risk of infection of more than 60.0%. The present study aimed to assess the level of understanding and awareness about Hepatitis B immunization among the first a...